ZEPP Company Profile and Key Details

Zepp Health Corporation has 7.04 million shares outstanding. The public float is 108.71 million shares, elevated short interest at 15.10% of float. This equals 910.73 thousand shares. The short ratio is 1.49 days. Institutional investors hold 68.33% of the float. Insiders own 7.64%.

Zepp Health Corporation earnings surprise history is frequent misses against expectations. The quarter that ended March 26, 2025, missed forecasts by -723.89%. The prior quarter beat by -558.55%. Over the last six quarters, Apple has recorded several small beats. These include -86.96% in November 20, 2023.

ZEPP has shown weak momentum, losing -13.46% over the past week and -55.11% over the past quarter, though year-to-date performance is down -14.29%. Short-term trend indicators are bullishly aligned (SMA20 4.06%, SMA50 -8.57%, SMA200 -14.67%). The stock’s 14-day RSI is 47.87 (neutral), while the ATR of 2.22 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -64.27% below its high and over 940.0% above its low. Average 10-day trading volume of 146.71 thousand shares is significantly above the 3-month average of 97.37 thousand, indicating heightened recent market interest.

Zepp Health Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$5.38. This means the shares are trading below this model’s fair value.

Zepp Health Corporation (NYSE:ZEPP) closed at $8.81 USD, losing -$0.41 (-4.45%) from the previous close of $9.22. The stock is currently mid-range between its 52-week high and low $2.22 and $61.85. With a market capitalization of about $126.18 million, Zepp Health Corporation is classified as a micro-cap and shows higher-than-market volatility (beta ~2.02). Key stats such as the average daily volume over the past year has been around 96.41 thousand shares, in line with its 52-week average. Headquartered in Hefei, None, Zepp Health Corporation operates in the Technology sector and the Consumer Electronics industry. Led by CEO Wang Huang, the company employs approximately 765 people and listed since February 08, 2018. Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China.

Zepp Health Corporation trades at a P/E ratio of -0.2, slightly below the S&P 500 average, with a price-to-sales ratio of 0.46 and a price-to-book ratio of 0.04 suggesting the stock is closer to book value. The P/FCF stands at -31.82, also below market averages.

Our AI price prediction model suggests that Zepp Health Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 16.35%, with price expected at $10.25 by June 02, 2026, within a range of $7.41 to $13.30 3-Month Outlook: Projected rise of 941.54%, reaching $91.76 by August 17, 2026, with a range of $90.87 to $92.61. 1-Year Outlook: Projected gain of 70.03%, with price at $14.98 by May 19, 2027, within a range of $14.40 to $15.45.

Zepp Health Corporation (NYSE:ZEPP) shares are down -14.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Zepp Health Corporation trading at a premium to the broader market with a P/E of -0.2. Our AI forecast model points to short-term strength (16.35% over two weeks), a medium-term rise (941.54% over three months), and a longer-term gain (70.03% over one year), with expected trading ranges indicating moderate volatility.